Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00003793
Other study ID # AB9804
Secondary ID COG-AB9804CCG-B9
Status Completed
Phase N/A
First received November 1, 1999
Last updated August 4, 2014
Start date December 1998
Est. completion date March 2007

Study information

Verified date August 2014
Source Children's Oncology Group
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

RATIONALE: Determination of genetic markers for soft tissue sarcoma or rhabdomyosarcoma may help doctors identify patients who are at risk for therapy-related leukemia.

PURPOSE: Clinical trial to study genetic testing of children with soft tissue sarcoma or rhabdomyosarcoma to identify children who are at risk of developing leukemia from the chemotherapy used to treat sarcoma.


Description:

OBJECTIVES:

- Identify genetically susceptible patients to therapy-induced myelodysplastic syndrome or acute myelogenous leukemia (t-MDS/AML) prior to initiation of high-dose chemotherapy for sarcoma.

- Identify patients who are at increased risk of t-MDS/AML during or after therapy.

OUTLINE: Blood is collected from patients at diagnosis (preferably before chemotherapy or transfusion), at end of therapy, and at 6 months, 1 year, 2 years, and 3 years after therapy.

Blood specimens are examined by clonality analysis (HUMARA), variant cell frequency (glycophorin A assay), GST NAT2/CYP1A1 genotyping, microsatellite instability, and ras mutation detection (single strand conformation polymorphism and sequencing of mutant alleles).

Patients do not receive the results of the genetic testing and the results do not influence the type or duration of treatment.

PROJECTED ACCRUAL: A total of 321 patients will be accrued for this study within 4 years.


Recruitment information / eligibility

Status Completed
Enrollment 294
Est. completion date March 2007
Est. primary completion date December 2005
Accepts healthy volunteers No
Gender Both
Age group N/A to 17 Years
Eligibility DISEASE CHARACTERISTICS:

- Diagnosis of sarcoma including:

- Rhabdomyosarcoma

- Ewing's sarcoma

- Primitive neuroectodermal tumor

- Fibrosarcoma

- Malignant peripheral nerve sheath tumor

- Synovial cell sarcoma

- Osteosarcoma

- Other soft tissue sarcoma

- Must be currently receiving intensive or high-dose chemotherapy for sarcoma

PATIENT CHARACTERISTICS:

Age:

- Children

Performance status:

- Not specified

Life expectancy:

- Not specified

Hematopoietic:

- Not specified

Hepatic:

- Not specified

Renal:

- Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy

- Not specified

Chemotherapy

- See Disease Characteristics

Endocrine therapy

- Not specified

Radiotherapy

- Not specified

Surgery

- Not specified

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Intervention

Genetic:
clonality analysis

microsatellite instability analysis

mutation analysis


Locations

Country Name City State
Australia Office of S. David Lang Herston, Brisbane Queensland
Australia Royal Children's Hospital Parkville Victoria
Australia Princess Margaret Hospital for Children Perth Western Australia
Canada IWK Health Centre Halifax Nova Scotia
Canada McMaster Children's Hospital at Hamilton Health Sciences Hamilton Ontario
Canada Cancer Centre of Southeastern Ontario at Kingston General Hospital Kingston Ontario
Canada Hopital Sainte Justine Montreal Quebec
Canada Children's Hospital of Eastern Ontario Ottawa Ontario
Canada Saskatoon Cancer Centre at the University of Saskatchewan Saskatoon Saskatchewan
Canada Centre Hospitalier Universitaire de Quebec Ste-Foy Quebec
Canada Hospital for Sick Children Toronto Ontario
Canada Children's & Women's Hospital of British Columbia Vancouver British Columbia
Canada CancerCare Manitoba Winnipeg Manitoba
United States Children's Hospital Medical Center of Akron Akron Ohio
United States Texas Tech University Health Sciences Center School of Medicine - Amarillo Amarillo Texas
United States C.S. Mott Children's Hospital at University of Michigan Ann Arbor Michigan
United States Winship Cancer Institute of Emory University Atlanta Georgia
United States CancerCare of Maine at Eastern Maine Medial Center Bangor Maine
United States Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx New York
United States Maimonides Cancer Center at Maimonides Medical Center Brooklyn New York
United States Roswell Park Cancer Institute Buffalo New York
United States Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina
United States West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division Charleston West Virginia
United States Blumenthal Cancer Center at Carolinas Medical Center Charlotte North Carolina
United States Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina
United States Children's Memorial Hospital - Chicago Chicago Illinois
United States Cincinnati Children's Hospital Medical Center Cincinnati Ohio
United States Cleveland Clinic Taussig Cancer Center Cleveland Ohio
United States Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri
United States Columbus Children's Hospital Columbus Ohio
United States Medical City Dallas Hospital Dallas Texas
United States Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas
United States Children's Medical Center - Dayton Dayton Ohio
United States Blank Children's Hospital Des Moines Iowa
United States Barbara Ann Karmanos Cancer Institute Detroit Michigan
United States Southern California Permanente Medical Group Downey California
United States INOVA Fairfax Hospital Fairfax Virginia
United States CCOP - MeritCare Hospital Fargo North Dakota
United States Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center Farmington Connecticut
United States Hurley Medical Center Flint Michigan
United States Lee Cancer Care of Lee Memorial Health System Fort Myers Florida
United States Cook Children's Medical Center - Fort Worth Fort Worth Texas
United States University of Florida Shands Cancer Center Gainesville Florida
United States Spectrum Health Hospital - Butterworth Campus Grand Rapids Michigan
United States St. Vincent Hospital Regional Cancer Center Green Bay Wisconsin
United States Greenville Hospital System Cancer Center Greenville South Carolina
United States Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods Michigan
United States Hackensack University Medical Center Cancer Center Hackensack New Jersey
United States Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania
United States Edwards Comprehensive Cancer Center at Cabell Huntington Hospital Huntington West Virginia
United States University of Mississippi Medical Center Jackson Mississippi
United States Nemours Children's Clinic Jacksonville Florida
United States CCOP - Kalamazoo Kalamazoo Michigan
United States Children's Mercy Hospital Kansas City Missouri
United States East Tennessee Children's Hospital Knoxville Tennessee
United States Jonathan Jaques Children's Cancer Center at Miller Children's Hospital Long Beach California
United States Jonsson Comprehensive Cancer Center at UCLA Los Angeles California
United States Kosair Children's Hospital Louisville Kentucky
United States Covenant Children's Hospital Lubbock Texas
United States Children's Hospital Central California Madera California
United States Marshfield Clinic - Marshfield Center Marshfield Wisconsin
United States Baptist-South Miami Regional Cancer Program Miami Florida
United States Miami Children's Hospital Miami Florida
United States Children's Hospitals and Clinics of Minneapolis Minneapolis Minnesota
United States University of Minnesota Medical Center & Children's Hospital - Fairview Minneapolis Minnesota
United States Vanderbilt-Ingram Cancer Center Nashville Tennessee
United States Children's Hospital of New Orleans New Orleans Louisiana
United States Herbert Irving Comprehensive Cancer Center at Columbia University New York New York
United States Mount Sinai Medical Center New York New York
United States NYU Cancer Institute at New York University Medical Center New York New York
United States Children's Hospital of The King's Daughters Norfolk Virginia
United States Oklahoma University Medical Center Oklahoma City Oklahoma
United States Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando Florida
United States St. Christopher's Hospital for Children Philadelphia Pennsylvania
United States Children's Hospital of Pittsburgh Pittsburgh Pennsylvania
United States Institute of Oncology at Vilnius University Portland Oregon
United States Mayo Clinic Cancer Center Rochester Minnesota
United States Methodist Children's Hospital of South Texas San Antonio Texas
United States University of Texas Health Science Center at San Antonio San Antonio Texas
United States UCSF Comprehensive Cancer Center San Francisco California
United States Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia
United States Maine Children's Cancer Program Scarborough Maine
United States Providence Cancer Center at Sacred Heart Medical Center Spokane Washington
United States Siteman Cancer Center at Barnes-Jewish Hospital St. Louis Missouri
United States All Children's Hospital St. Petersburg Florida
United States Stanford Comprehensive Cancer Center at Stanford University Medical Center Stanford California
United States Stony Brook University Cancer Center Stony Brook New York
United States SUNY Upstate Medical University Hospital Syracuse New York
United States St. Joseph's Cancer Institute at St. Joseph's Hospital Tampa Florida
United States CCOP - Scott and White Hospital Temple Texas
United States Children's National Medical Center Washington District of Columbia
United States Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington District of Columbia
United States Kaplan Cancer Center at St. Mary's Medical Center West Palm Beach Florida
United States Alfred I. duPont Hospital for Children Wilmington Delaware
United States Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina
United States Tod Children's Hospital - Forum Health Youngstown Ohio

Sponsors (2)

Lead Sponsor Collaborator
Children's Oncology Group National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Australia,  Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Event Free Survival No
See also
  Status Clinical Trial Phase
Recruiting NCT05691608 - MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 N/A
Recruiting NCT04092803 - Virtual Reality as a Distraction Technique for Performing Lumbar Punctures in Children and Young Adu N/A
Active, not recruiting NCT02530463 - Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome Phase 2
Completed NCT00948064 - Vorinostat in Combination With Azacitidine in Patients With Newly-Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Phase 2
Completed NCT04474678 - Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") N/A
Terminated NCT00801931 - Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders Phase 1/Phase 2
Recruiting NCT03948529 - RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation Phase 2
Completed NCT01682226 - Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies Phase 2
Completed NCT00003270 - Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer Phase 2
Active, not recruiting NCT02723994 - A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia Phase 2
Terminated NCT02469415 - Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) Phase 2
Recruiting NCT04856215 - 90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia Phase 2
Recruiting NCT06155188 - Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia N/A
Completed NCT00001637 - Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults Phase 2
Active, not recruiting NCT04188678 - Resiliency in Older Adults Undergoing Bone Marrow Transplant N/A
Completed NCT02910583 - Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) Phase 2
Completed NCT01212926 - Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain N/A
Terminated NCT00014560 - Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Phase 1
Recruiting NCT04977024 - SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer Phase 2
Recruiting NCT05866887 - Insomnia Prevention in Children With Acute Lymphoblastic Leukemia N/A